National Lipid Association
@nationallipid
Followers
12,797
Following
8,225
Media
1,961
Statuses
6,079
A non-profit, multi-disciplinary medical society focused on enhancing the practice of lipid management in clinical medicine.
Jacksonville, FL US
Joined April 2009
Don't wanna be here?
Send us removal request.
Explore trending content on Musk Viewer
#いい推しの日
• 384631 Tweets
SAROCHA X CAMPER OPENING STORE
• 129693 Tweets
連休最終日
• 112378 Tweets
Khalistani
• 102365 Tweets
Batman
• 68005 Tweets
私の推し
• 59996 Tweets
TXT OVER THE MOON
• 54310 Tweets
Ahmet Türk
• 24711 Tweets
CAMPER X PANSA
• 21056 Tweets
Happy New Week
• 20821 Tweets
H3ロケット4号機
• 17961 Tweets
PRABOWO Langsung Gercep Kerja
• 17958 Tweets
Gak Ada Waktu Santai
• 17924 Tweets
#TXT_SANCTUARY
• 16953 Tweets
#njpst
• 16945 Tweets
TXT SANCTUARY OUT NOW
• 16781 Tweets
最高の推し
• 16544 Tweets
#ポテト250円になるから250個あげる
• 15960 Tweets
Halfeti
• 15401 Tweets
Quincy Jones
• 14926 Tweets
#kayyım
• 13287 Tweets
JBCスプリント
• 13021 Tweets
神奈川県警
• 10209 Tweets
Congrats to
@PeterAttiaMD
on his NLA Honorary Lifetime Membership Award - what an honor to have you as a lifetime member!
7
8
134
📢 Update: The correct version of our infographic on the Role of ApoB in Clinical Management of Cardiovascular Risk in Adults is now available! Be sure to check out the accurate info
here:
#CardioRisk
#ApoB
#HealthCare
1
46
110
JUST RELEASED by
@nationallipid
: A helpful infographic based on the recently released NLA Scientific Statement, "Effects of Low-Carbohydrate and Very-Low-Carbohydrate Diets (Including Ketogenic) - Cardiometabolic Impact." For a downloadable PDF go to:
46
28
97
Protect your heart ❤️ Elevated LDL-C doesn't just raise numbers; it raises risks for atherosclerosis, heart disease, heart attacks, and strokes. Take action for a healthier tomorrow for our patients!
#HeartHealth
#KnowYourNumbers
"
#HeartMonth
#LipidSpecialist
#LearnYourLipids
2
19
67
Don't miss our
#TwitterChat
on the 2018
#Cholesterol
Guidelines at 7pm EST on Wed., Feb. 6!
#NLAChat
@ACCinTouch
@ASPCardio
@American_Heart
@HeartNurses
@pharmacists
@AACVPR
@AAPAorg
@AmDiabetesAssn
@AmerGeriatrics
@ACPM_HQ
3
25
62
BREAKING NLA NEWS:
NLA Announces Position on the Use of Icosapent Ethyl on High and Very-High-Risk Patients. Don’t miss this special session at 3:15 p.m. in Great Northern.
4
19
58
Now Available! The NLA's Scientific Statement: A Focused Update to the 2019 Scientific Statement on Use of Lipoprotein(a) in Clinical Practice. Read the Statement and access the infographic here:
@MarlysLPA
@CBallantyneMD
@dan_soffer
0
25
55
Dr. Saseen officially assumed the role of President at the NLA virtual business meeting on June 8 after serving for the past year as President-Elect. He succeeds Houston-based lipidologist Antonio Gotto, MD, DPhil, FNLA. The NLA looks forward to an amazing year with Dr. Saseen!
4
8
53
Get an introductory review of the core curriculum in Clinical Lipidology with this virtual live course on November 19-20 designed for any healthcare professional seeking to learn the fundamentals of Lipidology. Check out more info and REGISTER NOW! 👉
0
4
48
1
62
51
🚨Today is Lp(a) Awareness Day!
Let's use our voices to shed light on the significance of Lp(a) testing. Early detection can be pivotal in preventing cardiovascular diseases. Join us in ensuring everyone knows why it's crucial to
#KnowLpa
@TheFHFoundation
0
19
48
New NLA Scientific Statement: Lipid Measurements in the Management of Cardiovascular Diseases: Practical Recommendations - A Scientific Statement from the National Lipid Association.
ACCESS NOW:
2
24
51
CHECK THIS OUT. As follow-up to the Lipoprotein(a) official scientific statement presented at
#NLASessions
, a microsite has been created with helpful CLINICAL RESOURCES including a link to the Journal article, slides & a NEW patient infographic:
2
19
50
The NLA and the
@foundationofnla
support the
@AmerAcadPeds
recommendation that all children should receive dyslipidemia screening between 9-11 and again between 17-21 years old.
2
28
48
Today is Lipoprotein(a) Awareness Day! Raise awareness about this inherited disorder & make a difference for those who might not know about this common genetic condition
#KnowLpa
@TheFHFoundation
@foundationofnla
Get more info at &
0
28
47
🚨BREAKING NEWS 🚨📣
Looking for guidance on treating statin intolerance!? The NLA released its scientific statement defining statin intolerance and exploring what options clinicians can provide to those affected. Read the full statement:
#nlasessions
0
25
49
💡Are you unable to tolerate statin therapy because of muscle pains? Well then, Bempedoic acid might be for you!
What is Bempedoic Acid?
It’s a medication used to lower cholesterol levels in adults. It's part of a new class of drugs called ATP citrate lyase inhibitors.
1
14
45
NLA Announces New Clinical Perspective at the
#NLASessions
: Nutrition Interventions for Adults with Dyslipidemia
👉
@carolkirkpat3
@GeetaSikand
@AspryKarenMD
4
19
44
NLA and
@ASPCardio
release joint clinical perspective on the Importance of LDL-C Measurement and Control as Performance Measures
@CBallantyneMD
@DrMarthaGulati
@virani_md
@VCUDPOSChair
@kcferdmd
@LipidJournal
0
18
42
What an incredible honor to be featured on Jeopardy last night!
@CBallantyneMD
@dan_soffer
@lipiddoc
@Drlipid
@DineshKalra
0
9
39
Get an advanced examination of the core curriculum in Clinical Lipidology with this virtual live course on December 3-4 designed for any healthcare professional with experience in lipidology. Check out more info and REGISTER NOW! 👉
1
3
36
We are proud to announce the release of our new mission statement at the 2024
#NLASessions
. We feel this better reflects our commitment to advancing the field of lipidology and are excited for what is up ahead!
0
15
38
Attend lipidology’s premier CME/CE event designed for the entire healthcare team featuring the latest in treatment advances and clinical trials, ethical dilemmas in lipidology, genetics, prevention, and more. 👉 Visit for more information and to register!
1
5
35
Statins are the cornerstone of therapy for lowering LDL-C. For patients requiring additional LDL-C reduction, adjunctive options like ezetimibe, PCSK9 inhibitors, & bempedoic acid offer further therapeutic strategies. Explore these avenues to optimize your patients' lipid mngmt.
1
5
36
Expert: Doctors’ ‘ignorance of nutrition’ is affecting patient outcomes
3
17
33
Global think tank on the clinical considerations & management of lipoprotein(a) published online by participants from
@nationallipid
@ABCardio1
@ACCinTouch
@American_Heart
@society_eas
@atherosociety
@HeartNurses
0
9
34
With
#ODYSSEY
outcomes released @
#ACC18
, what's next? Join us at
#NLASessions
4/26-29 in Las Vegas for an insightful discussion w/ Dr. Vera Bittner,
@PamelaBMorris
&
@rgiugliano
on
#ODYSSEY
,
#FOURIER
and their relevance in clinical practice. Register now:
0
15
31
🚀 Exciting news from
@NewAmsPharma
! Their Phase 3 BROOKLYN trial for Obicetrapib in HeFH patients showed remarkable results: LDL-C reduced by 36.3% at 84 days and 41.5% at 365 days! This is a significant milestone in treating HeFH!
1
11
33
Lipid testing is a must to understand heart disease risk. Pediatric guidelines recommend testing between 9-11 and 17-20. Earlier or more frequent testing may be recommended if a parent or child are at increased risk for heart disease
#HeartMonth
#LipidSpecialist
#LearnYourLipids
2
17
33
Evidence shows that extremely low levels of
#LDL
(either from genetics or medications) does not result in adverse effects.
#Ezetimibe
#LowLDL
2
20
32
National Lipid Association Releases Official Scientific Statement on Coronary Artery Calcium Scoring for ASCVD Risk Reduction
0
12
30
Exciting News from
@ionispharma
! Olezarsen has been granted Orphan Drug designation by the US FDA for the treatment of FCS. This designation represents a significant milestone in addressing rare & challenging diseases.
#OrphanDrug
#FDAApproval
#RareDisease
1
9
32
The NLA created this infographic on what you should know about biomarkers and advanced lipid testing! Share with your colleagues.
1
30
30
Calling all
#abstracts
! Submit your
#science
by January 28, 2019 to present at
#NLASessions
May 16-19, 2019 in Miami and to be published in the
@LipidJournal
#lipidology
#research
#atherosclerosis
#dyslipidemia
#hypertriglyceridemia
2
7
29
Today is FH Awareness Day, created by the
@TheFHFoundation
to raise awareness of this genetic disorder. FH is the most common genetic condition leading to early heart disease and is still highly underdiagnosed. Learn more at
#KnowFH
1
18
30
Our Expert Clinical Consensus was just released providing an overview of the physiologic and clinical considerations regarding the role of apoB measurement to guide clinical care based on the available scientific evidence and expert opinion
@dan_soffer
@marstonMD
@CBallantyneMD
Role of apolipoprotein B in the clinical management of cardiovascular risk in adults: An Expert Clinical Consensus from the National Lipid Association - Journal of Clinical Lipidology
@nationallipid
0
12
39
0
11
30
☝ Learn about clinical trials studying the efficacy of EPA & DHA, meet a virtual patient named Catherine & workshop her case to lower her risk for a cardiovascular event with the new NLA activity: Triglyceride Lowering & Cardiovascular Outcomes here ➡️
1
8
28
PCSK9 Materials NOW AVAILABLE ONLINE: Updated recommendations developed by
@nationallipid
experts to assist clinicians with identifying patient groups in which use of PCSK9 mABs provides a reasonable value:
@heartnurses
@USPHSPharmacists
@FamilyMedForum
1
22
29
On Monday, the NLA DE&I Task Force will launch a 21 day education challenge, raising awareness diversity, equity, and inclusivity in our lipidology and prevention space. Follow
@nationallipid
and visit for more information.
2
10
29
Is the rising tide of support for
#EPA
warranted or just another fish-tale? 🐠 The NLA is covering the evidence supporting the benefit of omega-3 fatty acids and the recent clinical trials.
#NLASpringCLU
0
7
25
❗Free CME/CE Alert!
This CME activity features 3 leading experts focusing on addressing the HDL hypothesis, what we have learned from the past, and its potential for the future.
@CBallantyneMD
@DrRSRosenson
@HealioCME
Check it out!
0
9
28
Thank you to all who attended the successful 2020 Spring CLU in Denver held this past weekend that featured comprehensive scientific program-at times there was standing room only! 🙌 We look forward to seeing you at the NLA Scientific Sessions on June 4-7 in Chicago
#NLASessions
0
6
28
Lipid Conundrum
43M w CAC 32 (LAD) 3y ago. Placed on Rosuva 20, Ez 10 daily. Repeat CAC 92 (LM, LAD, RCA). Stable & recent lipids: TC 99 LDL-c 37 (baseline 130), TG 50, ApoB 45, Lp(a) 29 nmol/L. Father died MI @ 62. Very athletic. What do you do next?
27
4
28
🚨 The NLA has rescheduled the NLA 2020 Scientific Sessions to Dec 13-16, 2020. We look forward to delivering the most valuable & timely education to healthcare professionals dedicated to the management of dyslipidemia. 👉 Visit for more information.
0
8
28
#ThreadThursday
Deep Dive into Lp(a)
Join us today w/ our experts
@MarlysLPA
@DrSafarova
@CBallantyneMD
& more! They’ll share insights & discuss their publication on Lp(a)
Ask your questions & read the publication
#LipidXcellence
#CholesterolMonth
5
11
26
Keeping blood cholesterol at optimal levels is essential to a
#hearthealthy
lifestyle. Check out this
#NLA
tear sheet discussing the 2018 Guideline on the Management of Blood
#Cholesterol
:
#HeartMonth
#lipids
#lipidology
#hearthealth
3
11
28
Don’t miss this evidenced-based review of
#cardiovascular
benefits associated with foods, beverages, and supplements. Read this article from
@JACCJournals
.
0
17
27
LATE BREAKING PRESENTATION at NLA virtual Sessions next week: First Human Trial of a Loading Dose of Icosapent Ethyl in Patients with COVID-19: Primary Results of the VASCEPA COVID-19 CardioLink-9 Randomized Trial. Presenting author
@DLBHATTMD
0
4
26
Available online and endorsed by the NLA: ECDP on Role of Nonstatin Therapies for LDL-Cholesterol Lowering in the Management of ASCVD
@JACCJournals
@ACCinTouch
@dmljmd
@PamelaBMorris
@CBallantyneMD
@minissianm
1
14
26
Starting cholesterol-lowering therapy early in life may help reduce cardiovascular disease (CVD) risk decades later, affirmed a large longitudinal study that generated a tool for lifetime risk assessment.
0
12
26
#FacultyForumFriday
is here!
@Drlipid
is with us to answer your questions throughout the day! Comment on this post with your question and tag
@Drlipid
!
#LipidXcellence
23
4
25
Q3: A calcium score (CAC) of zero at age 65 suggests low risk despite high
#cholesterol
and other known
#CVD
risk factors. Do you plan to use CAC to determine if
#statins
can be started? If statins should be stopped?
#NLAChat
2
4
26
FH Awareness Day was established by the FH Foundation to raise awareness of familial hypercholesterolemia worldwide during Cholesterol Education Month. Together, we raise our voices in our local communities, in clinics, and on social media to help people
#KnowFH
.
#FHCantWait
1
9
26
NEWS: Alan S. Brown, MD (
@alanbrownmd
) officially takes the reins as
#NLA
President ➡️
#NLASessions
@advocatehealth
@LoyolaHSD
#LoyolaStritch
3
7
25
1/🧵
A reflection on equality versus equity - what do you see? Visit to participate in the
#NLADEI
#21daychallenge
#reflect
3
14
25
Lp(a) Conundrum
65 y Black woman NSTEMI with 1 stent (6 mo ago). On rosuva 40mg daily: TC 132, HDL 45, TG 100, LDL-C 68, Lp(a) 100 mg/dL. What next? Add therapy? If yes: eze? PCSK9i? bempedoic acid?
@ErinMichos
@Lpa_Doc
@alanbrownmd
@Drlipid
@MWilkinsonMD
@PamTaubMD
10
5
25
FDA approves Novartis Leqvio® (inclisiran), first-in-class siRNA to lower cholesterol and keep it low with two doses a year
0
8
25
JUST RELEASED: The manuscript for the long-awaited
#NLASessions
presentation, by Dr. Jennifer Robinson, "Enhancing the Value of PCSK9 Monoclonal Antibodies by Identifying Patients Most Likely to Benefit" is live now. The full manuscript can be read here:
0
14
25
IMPORTANT UPDATE:
#NLAFallCLU
accredited program: The Evolving Landscape of Triglyceride Lowering and Cardiovascular Outcomes: Clinical Pearls and Patient Application, Friday, 9/13, 7-9 PM featuring Dr. Ann C. Skulas-Ray,
@lipiddoc
Dr. James Underberg, and Dr. Kevin C. Maki.
0
4
23
Thank you
@society_eas
for an excellent joint session at our
#summeroflipids
meeting. Great presentations from
@LaleTokgozoglu
@DrLaxmiMehta
@EugeniaGianos
Dr. Jeanine Roeters van Lennep moderated by
@PamelaBMorris
on women, atherosclerosis and lipids.
0
3
24
Every member gets something different out of the NLA. 🎉This Membership Monday Dr. Gina Lundberg shares why she loves being an NLA member and what she gets out of her membership! Dr. Lundberg currently serves on the Women's Health Workgroup and several NLA committees.
1
5
22
2022 EAS Consensus Statement on Lp(a) in ASCVD & Aortic Stenosis available here:
Discover what's new since the 2010 EAS Consensus Statement was released
@ESCardioNews
@escardio
0
8
23
We are ready for the great debate coming up at
#NLASessions
between
@CBallantyneMD
and
@AllanSniderman
- Shifting to ApoB as the Primary Measure and Target of Therapy. Are you for or against?
Don't miss the great debate - register now
2
4
23
❗ Just Released: Dr. Alan Brown sits down with Dr. David Davidson to discuss gaps in care when treating patients with Familial Hypercholestrolemia. 🔊 Listen to Episode 2 of Lipid Insights at or on your favorite podcast platform.
0
7
23
The NLA and
@ASPCardio
contend that an LDL-C performance measure is essential for CVD risk reduction. Read their joint clinical perspective in the
@LipidJournal
here 👉
#CholesterolEducationMonth
#hearthealth
#CVD
0
4
23
Dr.
@PamelaBMorris
is a powerhouse. Proud to have her as a
@nationallipid
member.
LDL & Beyond Roundtable Co-Chair
@PamelaBMorris
offered final remarks and 🔑 takeaways: "We may be using an inaccurate measurement in order to guide complex decision-making in dyslipidemia. There is a need for a more accurate assessment."
1
3
21
0
4
22
The NLA proudly announces the 2023 Winner of the W. Virgil Brown Distinguished Achievement Award: Dr. Dan Rader!
He will be presenting in Atlanta, GA at the
#NLASessions
on Friday, June 2 at 10:30am ET.
View agenda and register:
Congrats Dr. Rader!
1
2
22
Today is National Wear Red Day! ❤️ At the National Lipid Association we support women's heart health.
#WearRedDay
and
#GoRed
0
4
23
📢CME/CE Alert! Free online activity on HDL with
@CBallantyneMD
@DrRSRosenson
and Dr. Vera Bittner and
@HealioCME
Take the activity:
0
6
22
On the 4th annual National Triglycerides Day, 🩸 visit our Triglyceride Activity Center, featuring activities and resources to strengthen your knowledge of triglyceride lowering, EPA and DHA, clinical trials and more 👉 View the activity center here!
0
10
22
Today is
#NationalTriglyceridesDay
. High triglycerides are associated with
#CVD
risk, and it is important to know the answer to
#WhatsYourNumber
? Share this helpful tear sheet from
@LearnYourLipids
>
#TGDay2018
(Infographic:
@Amarincorp
)
0
18
20
Today is
#NationalTriglyceridesDay
, a day to raise awareness about the importance of maintaining healthy triglyceride levels. You can access info for your patients with the
@foundationofnla
at 👉
1
6
22
Get the most up-to-date statistics related to heart disease, stroke, & CV risk factors, including core health behaviors and health factors that contribute to cardiovascular health
here 👉
@foundationofnla
#CholesterolEducationMonth
#hearthealth
#CVD
0
9
22
Happy
#NationalNursesDay
from the
#NLA
! Thank you to all of our members who are nurses for the important work you do!
0
13
20
And we are off!
#NLASessions
just started with Session I featuring
@JSaseenPharmD
@dan_soffer
@PamelaBMorris
Anne Goldberg Bruce Warden
0
5
21
Novo Nordisk A/S: Semaglutide 2.4 mg reduces the risk of major adverse cardiovascular events by 20% in adults with overweight or obesity in the SELECT trial
0
6
21
Looking for a concise reference on genetic testing in dyslipidemia? Check out the NLA's new infographic reviewing topics from NLA’s recently published manuscript, “Genetic Testing in Dyslipidemia,” published in the JCL. View the infographic & manuscript 👉
0
9
21
Join our experts live from your home for 2 full days, lecturing on advanced concepts & guiding participants through learning scenarios that provide tools & skills to further advance personal standards of practice
@lipiddoc
@dan_soffer
@carolkirkpat3
2
6
21
From the
#NLA
's Clinician's Lifestyle Modification Toolbox: Important tips for fortifying your
#diet
with much-needed soluble
#fiber
.
#HeartMonth
#hearthealth
#cholesterol
#lipids
#lipidology
#nutrition
#diet
1
11
20
AVAILABLE NOW❗ Did Part 1 of the latest episode of Lipid Insights leave you wanting more? In Part 2
@DLBHATTMD
and
@CBallantyneMD
discuss the controversies surrounding the REDUCE-IT Trial.🔊 Listen to Part 2 now at or on your favorite podcast platform.
0
7
19
Best of luck to
@TheFHFoundation
with its upcoming
#FHSummit19
. We're looking forward to the Tweets and reports coming out of the gathering!
We are looking forward to
#FHSummit19
. If you can't join us this year, you are free to watch the opening on Facebook Live.
#KnowFH
1
2
27
1
4
20
Another CME/CE sympo added to the
#NLASessions
! Join
@CBallantyneMD
@DrRSRosenson
and Dr. Vera Bittner for this exciting program.
Learn more about the
#NLASessions
coming up in June and register at
0
4
20
0
9
20
On the 3rd annual National Triglycerides Day, 🩸 We are excited to announce the launch of "Triglyceride Lowering and Cardiovascular Outcomes: Answers from the Experts", an interactive educational guide for clinicians. 👉 View the activity here
0
9
20
Congratulations (L to R): Terry A. Jacobson, MD, FNLA, Peter H. Jones, MD, FNLA, Carl E. Orringer, MD, FNLA, Marlys Koschinsky, PhD, CLS, FNLA, Catherine J. McNeal, MD, PhD, FNLA, and Don P. Wilson, MD, FNLA for your stellar work on the NLA Lipoprotein(a) Scientific Statement.
1
5
20
Today is National Lipid Day! National Lipid Day is celebrated annually on May 10 to raise awareness of dyslipidemia, a condition resulting in an abnormal increase of lipids in the blood. ▶️ Learn more:
0
12
20
Recurring lipid measurements are essential to understating LDL-C, optimizing patient care and preventing ASCVD
#HeartMonth
#LipidSpecialist
#LearnYourLipids
1
6
19
Great clinical consensus statement on acute LDL-C reduction post ACS with
@escardio
#ACVC
#EAPC
@ESC_Journals
1
9
19
Today is
#LpaAwarenessDay
! Join us in raising awareness today and every day about this inherited disorder and why you should
#KnowLpa
. Learn more at
0
5
19
Welcome to National Cholesterol Education Month! The NLA and the Foundation of the NLA look forward to an exciting month showcasing members & leaders on social media practicing what they preach: participating in staying active and having healthy eating habits!
0
4
19
📣 Check out LipidPALOOZA! Friday, September 4 kicks off the National Lipid Association’s first day of FREE education as part of LipidPALOOZA in conjunction with National Cholesterol Education Month. Review the agenda and register here 👉 .
#lipidpalooza
0
8
19
The NLA encourages adults over the age of 20 to get their lipids measured at least once every 5 years. Encourage your patients to understand why they should get lipid testing. They can access resources at
@foundationofnla
#CholesterolEducationMonth
0
4
19
The official exchanging of the pins presentation. Thank you Joyce for your tremendous leadership!
#NLASessions
0
6
17
Studies highlight concerns over non-adherence to statin therapy. It's crucial for patients to understand the importance of consistent medication. Read more:
#HealthAwareness
#StatinAdherence
#CholesterolEducationMonth
2
9
19
Congratulations to Robert Eckel MD on being the W. Virgil Brown Distinguished Achievement Award winner!
#NLASessions
1
6
18